None listed
Conditions
Interventions
Intervention1: Fond de teint: Skin Foundation, Once to twice daily, Topical application
Control Intervention1: Not Applicable: NIL
Sponsors
LOREAL
Eligibility
Inclusion criteria
Inclusion criteria: Sex: female. ? Age: 18 ? 45 years old. ? Subject with all type of skin on the face. ? Subject usually wearing fairness cream. ? Subject with sensitive skin (50% of the subjects) ?Subject with normal eyes (10 subjects only) ?Subject with sensitive eyes (20 subjects only) ? Subject wearing contact lenses (20 subjects only) ? Subject having given freely and expressly their informed consent, cooperative and aware of the necessity and duration of the controls so that perfect adhesion to the protocol can be expected. ? Subject who is able to read and understand documents transmitted (consent and information form). ? Subject having an official domicile. ? Subject accepting not to apply cosmetic products other than those she usually applies on and at their usual frequency of application. ? Subject having access to health services.
Exclusion criteria
Exclusion criteria: Subject who is pregnant or nursing or who is planning a pregnancy during the study, ? Current use of immunosuppressive drugs and/or an organ transplant, ? Current use of topical or systemic anti-inflammatory drugs for a defined medical condition, e.g. aspirin, ibuprofen, corticosteroids, ? Application within the last two months of any anti-inflammatory drug to skin area to be used in studying, ? Insulin-dependent diabetes, ? Currently receiving allergy injections, final injection within the last week, or expecting to begin injections during the course of the study, ? Immune deficiency or autoimmune disease, ? Skin disorders affecting the study area which, in the investigators? judgment, would interfere with grading / assessment of skin response (e.g. acne, psoriasis, disorders of pigmentation, scars, hyperhidrosis, etc, ?), ? Subjects with any skin disorder that could compromise evaluation of skin reactions, ? Subject having ocular pathology other than the one which involves allergy to some substance thereby causing sensitive eyes. ? Vaccination during the three weeks preceeding the study or intention to be vaccinated during the course of the study, ? A condition or medication which, in the investigator?s judgment, makes the subject ineligible or places the subject at undue risk, ? Current participation in another clinical study of any kind, ? Subject who is unwilling or unable to give informed consent or to otherwise comply with protocol requirements, ? Subject who cannot be contacted in case of emergency, ? Febrile disease in the three days preceding the study. ? Personnel of the investigating laboratory
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cutaneous and ocular acceptabilityTimepoint: Day 0 and Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| SUBJECTIVE EVALUATION OF COSMETIC ACCEPTABILITY BY THE SUBJECTSTimepoint: DAY 7 | — |
Countries
India
Contacts
Public ContactRashi Nangia
Outcome results
None listed